Business
CanSino CEO Sees Potential in China's Vaccine Market
March 31, 2026
Bloomberg
Scroll
CanSino Biologics Chairman and CEO Xuefeng Yu highlighted the company’s resilience last year despite China's falling birth rate and economic pressures. In an exclusive interview with Bloomberg's The China Show, he noted that the country's aging population offers growth potential for the vaccine market, bolstered by favorable government policies and CanSino’s product pipeline.
(Source: Bloomberg)
Bloomberg
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: lean left